Login / Signup

siRNA-loaded liposomes: Inhibition of encystment of Acanthamoeba and toxicity on the eye surface.

Kathrin FaberGiovanni K ZorziNathalya T BrazilBeni Jequicene Mussengue ChaúqueHelder Ferreira Teixeira
Published in: Chemical biology & drug design (2017)
DOPE:DSPE-PEG liposomes were prepared by three different techniques and used to associate a therapeutic siRNA sequence. Liposomes prepared by film hydration followed by membrane extrusion were considered the most adequate ones with average size of 250 nm and zeta potential of +45 mV, being able to associate siRNA for at least 24 hr in culture medium. siRNA-liposomes could inhibit up to 66% of the encystment process. Cell viability studies demonstrated MTT reduction capacity higher than 80% after 3 hr incubation with this formulation. After 24 hr of incubation, LDH activity ranged for both the formulations from around 4% to 40%. In vivo tolerance studies in mice showed no macroscopic alteration in the eye structures up to 24 hr after eight administrations during 1 day. Histological studies showed regular tissue architecture without any morphological alteration. Overall, these results suggest that the formulations developed are a promising new strategy for the treatment of ocular keratitis caused by Acanthamoeba spp.
Keyphrases
  • drug delivery
  • cancer therapy
  • drug release
  • case control
  • hyaluronic acid
  • type diabetes
  • photodynamic therapy
  • oxidative stress
  • skeletal muscle
  • adipose tissue
  • mass spectrometry
  • room temperature
  • reduced graphene oxide